Skip to content

Subscription

Turn on notifications to stay up to date with new posts.

Sam Altman invests $250 million in Merge Labs — a competitor to Neuralink

Published 1 min read
Sam Altman invests $250 million in Merge Labs — a competitor to Neuralink

The Tech AI

Get the key points in seconds - a short summary from The Tech AI.

Sam Altman is investing in Merge Labs, a startup developing brain-computer interfaces. The company raised $250 million at a valuation of $850 million, with a significant portion of the funding provided by OpenAI's venture capital arm. The founders are Altman and Alex Blania. The funds will be used for research and clinical trials. The main competitor is Elon Musk's Neuralink, valued at approximately $9 billion after raising $650 million.

The Tech on Telegram

Keep up with the latest technology and startup news.

Subscribe
News Courses Events Jobs Podcasts

Loading next post…